Literature DB >> 21374672

Optimal duration of treatment for acute hepatitis C in human immunodeficiency virus-positive individuals?

Gail V Matthews, Gregory J Dore.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21374672      PMCID： PMC3311112          DOI： 10.1002/hep.24152

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  3 in total

1.  Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference.

Authors: 
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

2.  Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: the HEPAIG study.

Authors:  Lionel Piroth; Christine Larsen; Christine Binquet; Laurent Alric; Isabelle Auperin; Marie-Laure Chaix; Stéphanie Dominguez; Xavier Duval; Anne Gervais; Jade Ghosn; Elisabeth Delarocque-Astagneau; Stanislas Pol
Journal:  Hepatology       Date:  2010-11-09       Impact factor: 17.425

3.  Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.

Authors:  Gregory J Dore; Margaret Hellard; Gail V Matthews; Jason Grebely; Paul S Haber; Kathy Petoumenos; Barbara Yeung; Philippa Marks; Ingrid van Beek; Geoffrey McCaughan; Peter White; Rosemary French; William Rawlinson; Andrew R Lloyd; John M Kaldor
Journal:  Gastroenterology       Date:  2009-09-24       Impact factor: 22.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.